|
|
|
| Analysis of the prevalence of nonalcoholic fatty liver disease and its related diseases among faculties in a certain university in Beijing |
| LIU Ying1 YANG Liqiang2 |
1.Department of Internal Medicine, Hospital of Beijing Institute of Technology, Beijing 100081, China;
2.Department of Pain Treatment, Xuanwu Hospital, Capital Medical University, Beijing 100053, China |
|
|
|
|
Abstract Objective To explore the prevalence rate of nonalcoholic fatty liver disease (NAFLD) and the relationship between NAFLD and other diseases, in order to provide useful information for the prevention and treatment of NAFLD. Methods 2140 staffs of Beijing Institute of Technology, who underwent medical examination from October to December in 2016 at Hospital of Beijing Institute of Technology, were selected as the study objects. For each case, the height, weight, and waist circumference were measured, the biological tests of liver function, kidney function, blood lipid and blood glucose were taken，and the abdominal ultrasonography was performed. Firstly, according to their age, they were divided into two groups: age < 60 years (2099 cases) and age ≥ 60 years (41 cases). The prevalence rates of NAFLD between the two groups with different sex were compared. Then, according to the results of ultrasonography, there were 341 cases in NAFLD group and 1799 cases in non-NAFLD group. The prevalence rates of hypertension, diabetes, dyslipidemia, hyperuricemia and obesity between NAFLD group and non- NAFLD group were compared. Results The prevalence rate of NAFLD was 15.93% cases (341/2140) in this study. The prevalence rate of NAFLD in male was significantly higher than that of female before the age of 60 (P < 0.01), while there was no significant difference after the age of 60(P > 0.05). There was significantly higher morbidity rate of hypertension, diabetes, dyslipidemia, hyperuricemia and obesity in NAFLD group than that in non-NAFLD group (P < 0.05). Conclusion The prevalence rate of NAFLD in this university is at a higher level. The occurrence of NAFLD is closely related to lipid metabolic disorders. It is also a systemic disease which often combines with varies metabolic disorders, such as hypertension, diabetes, dyslipidemia, hyperuricemia and obesity. Some necessary measures should be taken for proactive prevention and treatment of NAFLD.
|
|
|
|
|
|
[1] 范建高.非酒精性脂肪性肝病的研究现状与展望[J].临床肝胆病杂志，2015，31（7）：999-1001.
[2] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南（2010年修订版）[J].中华肝脏病杂志，2010，18（3）：163-166.
[3] Oh H，Jun DW，Saeed WK，et al. Nonalcoholic fatty liver diseases：update on the challenge of diagnosis and treatment [J]. Clin Mol Hepatol，2016，22（3）：327-335.
[4] Berk PD，Verna EC. Nonalcoholic fatty liver diseases：lipids and insulin resistance [J]. Clin Liver Dis，2016，20（2）：245-262.
[5] Machado MV，Cortez-Pinto H. Diet，microbiota，obesity，and NAFLD：a dangerous quartet [J]. Int J Mol Sci，2016， 17（4）：481-500.
[6] Younossi ZM，Koenig AB，Abdelatif D，et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence，incidence，and outcomes [J]. Hepatology，2016，64（1）：73-84.
[7] Li Z，Xue J，Chen P，et al. Prevalence of nonalcoholic fatty liver disease in mainland of China：a Meta-analysis of published studies [J]. J Gastroenterol Hepatol，2014，29（1）：42-51.
[8] 向国卿，孟晓丹，王炳元，等.沈阳市不同职业人群脂肪肝的流行现状分析[J].临床肝胆病杂志，2010，26（3）：283-285.
[9] Green CJ，Hodson L. The influence of dietary fat on liver fat accumulation [J]. Nutrients，2014，6（11）：5018-5033.
[10] 赵鸿馨，闫蓉，牛春燕，等.西安地区青少年肥胖和非酒精性脂肪性肝病现状调查及相关危险因素分析[J].临床肝胆病杂志，2015，31（8）：1248-1251.
[11] 胡玲，李宇.中老年体检人群非酒精性脂肪肝患病率调查及与代谢相关因素的相关性[J].实用医学杂志，2017， 33（4）：632-635.
[12] 宋炜，刘桂琴，宋建奇，等. 2型糖尿病合并非酒精性脂肪性肝病相关影响因素分析[J].中国医药导报，2015， 12（17）：96-100.
[13] Wang Y，Li YY，Nie YQ，et al. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease [J]. Exp Ther Med，2013，6（1）：77-84.
[14] Guleria A，Duseja A，Kalra N，et al. Patients with non-alcoholic fatty liver disease（NAFLD）have an increased risk of atherosclerosis and cardiovascular disease [J]. Trop Gastroenterol，2013，34（2）：74-82.
[15] Armstrong MJ， Adams LA， Canbay A， et al. Extrahepatic complications of nonalcoholic fatty liver disease [J]. Hepatology，2014，59（3）：1174-1197.
[16] 路然，洪天配.脂质代谢紊乱导致非酒精性脂肪性肝病的发病机制[J].临床肝胆病杂志，2015，31（7）：1050-1054.
[17] Kuo CF，Yu KH，Luo SF，et al. Gout and risk of nonalcoholic fatty liver disease [J]. Scand J Rheumatol，2010，39（6）：466.
[18] 杨蕊旭，范建高.非酒精性脂肪性肝病的流行现状[J].临床内科杂志，2015，32（5）：293-296.
[19] 胡文义，马晓慧，李欣欣，等.非酒精性脂肪肝潜在药物研究进展[J].中国新药杂志，2017，26（14）：1661-1666.
[20] 信丰智，范建高.欧洲非酒精性脂肪性肝病诊疗指南简介[J].实用肝脏病杂志，2016，19（4）：519-520. |
|
|
|
